A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
for SARS-CoV-2
6 locations incl. Atlanta
Sponsor: ModernaTX, Inc.
Sex: All·Age: 6 Months+·Accepts healthy volunteers
Code: NCT06585241·Phase 4·Recruiting·Listed Sep 2024